Peringkat dalam Saham
#41523
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
Harga Saham
$0.05646911
Terakhir disinkronkan: 2025-05-28
Kapitalisasi Pasar
$17.31K
Perubahan (1 hari)
-1.67%
Perubahan (1 tahun)
0.00%
Perdagangan LungLife AI, Inc. (LLAI)
Harga LLAI dengan kapitalisasi pasar B
Kapitalisasi pasar dari LungLife AI, Inc.(LLAI)
Kapitalisasi Pasar: $17.31K
Per August 2026, LungLife AI, Inc. memiliki kapitalisasi pasar sebesar $17.31K. Ini menjadikan LungLife AI, Inc. sebagai perusahaan 41523rd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar LungLife AI, Inc. dari 2021 hingga 2026
LLAI dibandingkan dengan 5 teratas stocks paling populer
| Harga LLAI |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.383T
|
+31,094,965,478.92%
|
|
|
|
|
$4.423T
|
+25,550,067,333.60%
|
|
|
|
|
$4.160T
|
+24,030,820,100.90%
|
|
|
|
|
$3.663T
|
+21,159,804,698.00%
|
|
|
|
|
$2.891T
|
+16,700,103,346.88%
|
